Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 2
1995 1
1996 2
1997 3
1998 4
1999 1
2000 4
2001 2
2003 2
2004 3
2005 4
2006 2
2007 1
2011 1
2012 4
2013 2
2014 6
2015 3
2016 4
2017 1
2018 1
2019 2
2020 6
2021 2
2022 4
2023 8
2024 5
2025 6
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Among authors: ferrone pj. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
COMPLICATED CONGENITAL RETINOSCHISIS.
Savoie BT, Ferrone PJ. Savoie BT, et al. Among authors: ferrone pj. Retin Cases Brief Rep. 2017 Winter;11 Suppl 1:S202-S210. doi: 10.1097/ICB.0000000000000444. Retin Cases Brief Rep. 2017. PMID: 27680778
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial.
Khanani AM, Patel SS, Ferrone PJ, Osborne A, Sahni J, Grzeschik S, Basu K, Ehrlich JS, Haskova Z, Dugel PU. Khanani AM, et al. Among authors: ferrone pj. JAMA Ophthalmol. 2020 Sep 1;138(9):964-972. doi: 10.1001/jamaophthalmol.2020.2699. JAMA Ophthalmol. 2020. PMID: 32729897 Free PMC article. Clinical Trial.
Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension Study.
Goldberg RA, Boyer DS, Holz FG, MacCumber MW, Garg SJ, Brown DM, Lad EM, Steinle N, Rishi PS, Pearce I, Ach T, Ribeiro R, Li C, Jones D, Tsuboi M, Ferrone PJ, Baumal CR, Wykoff CC. Goldberg RA, et al. Among authors: ferrone pj. Ophthalmic Surg Lasers Imaging Retina. 2025 Jul;56(7):398-406. doi: 10.3928/23258160-20250217-01. Epub 2025 May 15. Ophthalmic Surg Lasers Imaging Retina. 2025. PMID: 40371972 Free article. Clinical Trial.
Ophthalmologic Presentations of Incontinentia Pigmenti.
Rai RS, Li AS, Ferrone PJ. Rai RS, et al. Among authors: ferrone pj. J Vitreoretin Dis. 2024 Jan 28;8(2):186-191. doi: 10.1177/24741264241227680. eCollection 2024 Mar-Apr. J Vitreoretin Dis. 2024. PMID: 38465353 Free PMC article.
Opportunity Cost of Vitreoretinal Surgeries.
Leung EH, Patel S, Reddy R, Boucher N, Sharma C, Blim J, Ferrone PJ, Hahn P; American Society of Retina Specialists Health Economics Committee. Leung EH, et al. Among authors: ferrone pj. J Vitreoretin Dis. 2023 Jun 17;7(4):275-280. doi: 10.1177/24741264231178590. eCollection 2023 Jul-Aug. J Vitreoretin Dis. 2023. PMID: 37927325 Free PMC article.
Ophthalmic Outcomes After Silicone Oil Removal.
Jiao G, Shah PP, Shakin EP, Lee JG, Ferrone PJ, Rhee DY, Romero JM, Rosenblatt BJ, Graham KB, Lin J. Jiao G, et al. Among authors: ferrone pj. J Vitreoretin Dis. 2024 Aug 15;8(6):681-686. doi: 10.1177/24741264241271645. eCollection 2024 Nov-Dec. J Vitreoretin Dis. 2024. PMID: 39554621 Free PMC article.
Aflibercept-Related Sterile Intraocular Inflammation Outcomes.
Greenberg JP, Belin P, Butler J, Feiler D, Mueller C, Tye A, Friedlander SM, Emerson GG, Ferrone PJ; Aflibercept Sterile Inflammation Research Group. Greenberg JP, et al. Among authors: ferrone pj. Ophthalmol Retina. 2019 Sep;3(9):753-759. doi: 10.1016/j.oret.2019.04.006. Epub 2019 Apr 11. Ophthalmol Retina. 2019. PMID: 31153850
80 results